`571.272.7822
`
`
`
`
`
`
`Paper 37
`Entered: July 27, 2018
`
` UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`INFOBIONIC, INC.,
`Petitioner,
`
`v.
`
`BRAEMAR MANUFACTURING, LLC,
`Patent Owner.
`____________
`
`Case IPR2017-00796
`Patent RE43,767 E
`____________
`
`
`
`Before PHILLIP J. KAUFFMAN, KEVIN W. CHERRY, and
`MICHAEL L. WOODS, Administrative Patent Judges.
`
`WOODS, Administrative Patent Judge.
`
`
`
`
`
`FINAL WRITTEN DECISION
`35 U.S.C. § 318(a) and 37 C.F.R. § 42.73
`
`
`
`IPR2017-00796
`Patent RE43,767 E
`
`
`I.
`
`INTRODUCTION
`
`InfoBionic, Inc. (“Petitioner”), filed a Petition (Paper 1, “Pet.”)
`
`requesting inter partes review of all claims, namely, claims 1–9 and 11–26
`
`of U.S. Patent No. RE43,767 E (Ex. 1001, “the ’767 patent”). Pet. 1, 3; see
`
`also Ex. 1001, 8:31–33 (indicating that claim 10 has been cancelled).
`
`Braemar Manufacturing, LLC (“Patent Owner”), filed a Preliminary
`
`Response (Paper 10, “Prelim. Resp.”) to the Petition. We instituted an inter
`
`partes review of claims 1–9 and 11–26 of the ’767 patent as unpatentable
`
`under § 103. Paper 11, 2 (“Decision to Institute” or “Dec.”); see also Paper
`
`34, 2 (issuing order to institute on all grounds).
`
`After institution of trial, Patent Owner filed a Response (Paper 14,
`
`“PO Resp.”), to which Petitioner replied (Paper 18, “Pet. Reply”). With our
`
`authorization, Patent Owner also filed a Sur-Reply (Paper 24, “PO Sur-
`
`Reply”) to address arguments made by Petitioner in its Reply, and Petitioner
`
`filed a Sur-Sur-Reply (Paper 28, “Pet. Sur-Sur-Reply”) in response to Patent
`
`Owner’s Sur-Reply.
`
`Oral argument was conducted on May 1, 2018, and a transcript of the
`
`hearing is entered in the record. Paper 36 (“Tr.”).
`
`We have jurisdiction under 35 U.S.C. § 318(a). After considering the
`
`evidence and arguments of both parties, and for the reasons set forth below,
`
`we determine that Petitioner met its burden of showing, by a preponderance
`
`of the evidence, that claims 1–9 and 11–26 of the ’767 patent are
`
`unpatentable.
`
`
`
`2
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`II.
`
`BACKGROUND
`
`A.
`
`The ’767 patent (Ex. 1001)
`
`The ’767 patent is a reissue of U.S. Patent No. 6,694,177, and is titled
`
`CONTROL OF DATA TRANSMISSION BETWEEN A REMOTE
`
`MONITORING UNIT AND A CENTRAL UNIT. Ex. 1001, (54), (64).
`
`The ’767 patent describes a method for remotely monitoring a patient’s
`
`physiological condition. See id. at 1:12–15, 56–57; 2:1–3. In particular, the
`
`’767 patent purports to improve the efficiency of communication between a
`
`remote monitoring unit and a central monitoring unit (see id. at 1:66–2:37)
`
`and improve upon prior art systems that continuously monitor physiological
`
`characteristics of the patient (id. at 1:18–48). In doing so, the ’767 patent
`
`seeks to conserve battery power, reduce cellular data transfer and its
`
`associated charges, and reduce inefficient usage of medical personnel. Id.
`
`To illustrate the ’767 patent’s monitoring apparatus, we reproduce
`
`Figure 2, below:
`
`
`
`3
`
`
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`Figure 2 is a simplified schematic block diagram depicting monitoring
`
`apparatus 50 with remote monitoring unit (“RMU”) 52 (which is carried by
`
`a patient), central unit (“CU”) 54, and sensor 56. Ex. 1001, 3:33–35, 48–56.
`
`Sensor 56 communicates with RMU 52 (id. at 4:1–3) and measures a
`
`physiological characteristic of a patient (id. at 3:55–56), such as heart rate,
`
`blood pressure, and respiration (see id. at 3:60–62). RMU 52 has central
`
`processing unit (“CPU”) 58 and transceiver 62, while CU 54 has CPU 60
`
`and transceiver 64. Id. at 4:1–17. CU 54 may also be provided with an
`
`interface for human (e.g., physician) review 66 of the action recommended
`
`by the CU’s CPU 60. Id. at 4:38–41. RMU 52 and CU 54 are placed in
`
`two-way communication with each other through transceivers 62, 64. Id. at
`
`4:13–17.
`
`As mentioned above, the ’767 patent purports to improve upon prior
`
`art systems and methods by reducing unnecessary data transfers. See id. at
`
`2:20–26. We reproduce Figure 1 of the ’767 patent, below
`
`
`
`4
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`
`
`Figure 1 is a block flow diagram that describes the “method for
`
`practicing the present invention.” Id. at 3:31–32. At step 22, RMU 52 uses
`
`sensor 56 to monitor a patient’s physiological data, the “monitored data set.”
`
`Id. at 4:42–47. At step 24, RMU 52 then analyzes the monitored data set to
`
`obtain a “derived data set,” which is typically smaller than the monitored
`
`data set. Id. at 4:48–65. At steps 26, 28, and 30, if RMU 52 (via CPU 58)
`
`determines that the derived data set indicates a possible emergency (e.g., the
`
`patient’s heart rate exceeds a limit), RMU 52 transmits “initially transmitted
`
`data set” to CU 54 immediately. Id. at 4:65–5:25. This initially transmitted
`
`data set may be the same or different from the derived data set. Id. at 5:29–
`
`30. At step 32, CU 54 then analyzes this initially transmitted data set to
`
`determine if more information is needed, and whether that information is
`
`needed immediately or not. See id. at 5:39–6:14. If more information is
`
`needed urgently, at steps 36, 38, CU 54 instructs RMU 52 to provide an
`
`
`
`5
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`“additional transmitted data set” immediately. Id. at 5:55–6:7. If CU 54
`
`determines that the additional transmitted data set is not needed urgently,
`
`and RMU 52 sends the additional transmitted data set at a later, delayed time
`
`(step 40). Id. at 5:55–6:14.
`
`In summary, the ’767 patent describes the following sets of
`
`information: (1) a monitored data set; (2) a derived data set; (3) an initially
`
`transmitted data set; and (4) an additional transmitted data set. By delaying
`
`non-urgent “additional transmitted data sets,” the ’767 patent purports to
`
`conserve battery power, reduce cellular data transfer—including its
`
`associated charges—and reduce inefficient usage of medical personnel. See
`
`id. at 1:44–48; see also id. at 2:65–3:4 (“[T]he central monitoring unit may
`
`instruct the remote monitoring unit to store and then transmit the additional
`
`transmitted data set at a later time over the land-line telephone terminal
`
`when such a connection is available or the radio frequency telephone
`
`connection when transmission costs are lower (i.e., off-peak hours).”)
`
`
`
`B.
`
`Related Matters
`
`Petitioner is a defendant in a lawsuit involving the ’767 patent. Pet. 2
`
`(referencing CardioNet, LLC et al. v. InfoBionic, Inc., No. 1:15-cv-11803
`
`(D. Mass.)); Paper 9, 2.
`
`
`
`C.
`
`Illustrative Claims
`
`Claims 1, 9, 16, 17, and 18 are independent. Ex. 1001, 7:1–10:63.
`
`Claim 17, reproduced below, illustrates the claimed subject matter (with
`
`emphases added to particular limitations discussed in this Decision):
`
`
`
`6
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`17. A method of monitoring a patient, comprising the
`steps of providing a monitoring apparatus including
`a remote monitoring unit associated with the patient, the
`remote monitoring unit including a sensor that measures a
`physiological characteristic of the patient,
`a central unit, and
`a communications device which selectively establishes a
`communications link between the remote monitoring unit and the
`central unit based on a condition sensed;
`the remote monitoring unit obtaining a monitored data set
`for the patient;
`the remote monitoring unit analyzing the monitored data
`set to obtain a derived data set from the monitored data set;
`the remote monitoring unit determining from the derived
`data set that communication with the central unit is required;
`establishing a communications link with the central unit;
`the remote monitoring unit transmitting to the central unit
`an initially transmitted data set related to the monitored data set;
`the central unit analyzing the initially transmitted data set
`to determine whether an additional data set related to the
`monitored data set is required to be transmitted by the remote
`monitoring unit; and
`the central unit instructing the remote monitoring unit that
`the additional data set related to the monitored data set is to be
`transmitted from the remote monitoring unit to the central unit
`and as to a time at which the additional data set is to be
`transmitted based on the condition sensed.
`
`Id. at 9:22–51 (original emphases and bracketed portions omitted, new
`emphases added).
`
`
`
`
`
`Petitioner relies on the following references:
`
`D.
`
`References
`
`Name
`Ferguson
`Kehr
`Yasushi
`Surwit
`
`Reference
`US 6,454,708 B1, issued Sept. 24, 2002
`WO 98/38909, published Sept. 11, 1998
`US 6,485,418 B2, issued Nov. 26, 2002
`US 6,980,958 B1, issued Dec. 27, 2005
`
`Ex. No.
`1004
`1005
`1006
`1007
`
`7
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`Name
`Walker
`
`
`Reference
`WO 98/50873, published Nov. 12, 1998
`
`Ex. No.
`1008
`
`E. Grounds Asserted
`
`Petitioner contends that claims 1–9 and 11–26 of the ’767 patent are
`
`unpatentable under the following grounds:
`
`Prior Art
`Ground
`Ferguson and Kehr
`1
`Ferguson, Kehr, and Yasushi
`2
`Ferguson, Kehr, and Surwit
`3
`4 Walker and Kehr
`5 Walker, Kehr, and Yasushi
`
`Claim(s)
`1–6, 9, 11–14, 16–20, 22, 24, and 26
`7, 15, 21, 23, and 25
`8
`1–6, 9, 11–14, 16–20, 22, 24, and 26
`7, 15, 21, 23, and 25
`
`Pet. 3.
`
`Petitioner also submits the declaration testimony of Dr. Robert T.
`
`Stone (Ex. 1002) in support of the grounds. Pet. vi.
`
`
`
`F. Decision to Institute
`
`On July 31, 2017, we instituted review of all challenged claims under
`
`Grounds 1–3. Paper 11 (“DI”), 2. As explained in our DI, however, we did
`
`not find persuasive Petitioner’s challenges under Grounds 4 and 5. See id. at
`
`35 (“Petitioner has not demonstrated a reasonable likelihood that it will
`
`prevail with regards to its challenge . . . under Ground 4 or . . . under Ground
`
`5.”). Rather, we found persuasive Patent Owner’s arguments in response to
`
`those grounds. See id. at 32 (citing Prelim. Resp. 35–36 (“Patent Owner’s
`
`argument is persuasive”)); see also id. at 27–34.
`
`On May 3, 2018, in response to the Supreme Court’s decision in SAS,
`
`we issued an order (“Order”) modifying our institution decision to institute
`
`on all of the grounds presented in the Petition, including Grounds 4 and 5.
`
`
`
`8
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`Paper 34, 2 (citing SAS Institute Inc. v. Iancu, 138 S. Ct. 1348 (2018)).
`
`On May 11, 2018, we held a conference call with the parties to
`
`discuss the impact of the Order in this proceeding, specifically, to discuss
`
`whether additional briefing would be necessary to respond to newly-
`
`instituted Grounds 4 and 5. See Paper 35, 2. During the conference call,
`
`Patent Owner expressed concern that its arguments presented in its
`
`Preliminary Response were not similarly presented in its Patent Owner
`
`Response, and even though we determined that those arguments were
`
`persuasive in our DI, those same arguments were waived as not being
`
`presented in its Patent Owner Response. See id. at 2–3 (citing Paper 12, 3).
`
`To address Patent Owner’s concerns, while keeping the proceeding
`
`on-schedule and without the need for additional briefing, we issued a second
`
`order. Id. In this second order, we established that the Board would
`
`consider Patent Owner’s arguments presented in its Preliminary Response
`
`(responding to Grounds 4 and 5, only) as if they had been similarly
`
`presented in its Patent Owner Response, and that those arguments would be
`
`considered by the Board in this Final Written Decision. See id. at 3
`
`
`
`III. ANALYSIS
`
`A.
`
`Claim Construction
`
`We determine that no claim term requires express construction for the
`
`purposes of this Decision. See Wellman, Inc. v. Eastman Chem. Co., 642
`
`F.3d 1355, 1361 (Fed. Cir. 2011) (“[C]laim terms need only be construed ‘to
`
`the extent necessary to resolve the controversy.’”) (quoting Vivid Techs.,
`
`Inc. v. Am. Sci. & Eng’g, Inc., 200 F.3d 795, 803 (Fed. Cir. 1999)).
`
`
`
`9
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`B. Obviousness
`
`A claim is unpatentable under 35 U.S.C. § 103 if the differences
`
`between the claimed subject matter and the prior art are “such that the
`
`subject matter as a whole would have been obvious at the time the invention
`
`was made to a person having ordinary skill in the art to which such subject
`
`matter pertains.” 35 U.S.C. § 103(a). The question of obviousness under 35
`
`U.S.C. § 103 is resolved on the basis of underlying factual determinations,
`
`including: (1) the scope and content of the prior art; (2) any differences
`
`between the claimed subject matter and the prior art; (3) the level of skill in
`
`the art; and (4) objective evidence of nonobviousness, i.e., secondary
`
`considerations. Graham v. John Deere Co., 383 U.S. 1, 17–18 (1966).
`
`
`
`C.
`
`Person of Ordinary Skill in the Art
`
`In determining whether an invention would have been obvious at the
`
`time it was made, we consider the level of ordinary skill in the pertinent art
`
`at the time of the invention. Graham, 383 U.S. at 17.
`
`Petitioner proposes that a person of ordinary skill in the art
`
`(“POSITA”) “would have at least a bachelor’s degree in a suitable
`
`engineering field . . . or equivalent proficiency, and at least two to three
`
`years of experience in the research and/or development of remote patient
`
`monitoring systems . . . where more education may substitute for relevant
`
`experience and vice versa.” Pet. 6–7 (citing Ex. 1002 ¶¶ 13–14).
`
`Patent Owner, on the other hand, proposes that a POSITA
`
`would have been a skilled individual with an electrical
`engineering undergraduate degree (or its equivalent) with at least
`two years of experience in the design and development of ECG
`telemetry devices or similar remote monitoring and telemetry
`
`
`
`10
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`devices and/or an undergraduate degree in engineering (or its
`equivalent) with at least four years of experience in the design
`and development of ECG telemetry devices or similar remote
`monitoring and telemetry devices.
`
`PO Resp. 10–11. Patent Owner also acknowledges that for “purposes of [its
`
`Patent Owner Response,] the differences between Petitioner’s and Patent
`
`Owner’s position do not appear to be material.” Id.
`
`Based on our review of the ’767 patent, the types of problems and
`
`solutions described in the ’767 patent and applied prior art, and the
`
`testimony of Dr. Stone and Dr. Fernald, we adopt Petitioner’s asserted level
`
`of ordinary skill and find that a POSITA
`
`at the time of the alleged invention would have at least a
`bachelor’s degree
`in a suitable engineering field (e.g.,
`mechanical or electrical), or equivalent proficiency, and at least
`two to three years of experience in the research and/or
`development of remote patient monitoring systems, such as
`cardiac remote patient monitoring systems, where more
`education may substitute for relevant experience and vice versa.
`Stone Decl. ¶¶ 13-14. This education and experience would
`include a solid familiarity with the communication between
`components of a patient monitoring system.
`
`Pet. 6–7 (citing Ex. 1002 ¶¶ 13–14). We also agree with Patent Owner that
`
`any differences in the parties’ proposed level of ordinary skill does not
`
`impact our analysis. See PO Resp. 8.
`
`
`
`D. Ground 1: Ferguson and Kehr
`
`Petitioner contends that claims 1–6, 9, 11–14, 16–20, 22, 24, and 26
`
`are unpatentable over Ferguson and Kehr. Pet. 14. Our Decision begins
`
`with a summary of the cited art and a summary of Petitioner’s challenge,
`
`
`
`11
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`followed by our analysis including consideration of Patent Owner’s
`
`arguments.
`
`
`
`1.
`
`Ferguson (Ex. 1004)
`
`Ferguson describes a patient monitoring system. Ex. 1004, 8:27–28.
`
`To illustrate Ferguson’s system, we reproduce Figure 1, below:
`
`
`
`As depicted in Figure 1, Ferguson’s system includes disposable sensor
`
`band 10 for measuring a patient’s vital signs, and memory card 20 for
`
`storing the associated data. Id. at 7:13–15; 8:29–33. The data may also be
`
`transmitted to base station unit 30. Id. at 8:35–37. Base station 30 is
`
`powered by a selectable 110/230V power supply and includes a modem
`
`connection (either a land telephone line or cellular link 40) for transmitted
`
`information. Id. at 11:10–15. Base station 30 may also contain software
`
`algorithms to enable the calculation of heart rate and respiration rate from
`
`the data signals. Id. at 12:19–22; 15:41–45. Base station unit 30 may then
`
`transmit the data over telecommunications link 40 to remote monitoring
`
`
`
`12
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`station 50. Id. at 8:36–40. Once a connection has been established, both
`
`ends of communications link 40 will listen for commands. Id. at 16:10–13.
`
`At station 50, an operator (e.g., physician or nurse) reviews the patient data
`
`and can request base station 30 to send more detailed data, and if the
`
`requested data is available, the base station will respond. Id. at 13:5–10, 29–
`
`31; 14:38–42. Remote monitoring station 50 may request an immediate data
`
`upload. Id. at 13:5–10. Remote monitoring station 50 may also set certain
`
`threshold events (e.g., high heart rate) to be flagged by base station 30, as
`
`well (id. at 22:5–21) and when such event is detected by base station 30, a
`
`recording session that records monitored parameters may occur. Id. at
`
`14:21–25.
`
`
`
`2.
`
`Kehr (Ex. 1005)1
`
`Kehr describes a device, system, and method for “managing and
`
`monitoring the administration of medical treatment regimens.” Ex. 1005, 6.
`
`To illustrate Kehr’s system, we reproduce Figure 24 of Kehr, below:
`
`
`1 Our citations to Exhibit 1005 will be to the reference’s native page
`numbers.
`
`
`
`13
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`
`
`In the particular embodiment of Figure 24, Kehr describes a system
`
`with medical monitoring device 5, which interfaces with sensors 107 (e.g., a
`
`heart monitor or glucose monitor) associated with a patient. Id. at 44–45.
`
`Central monitor 105 functions as a command and control center and may
`
`wirelessly obtain monitored data from sensors 107. See id. at 46. In the
`
`example where sensor 107 is a glucose level sensor, and if the patient’s
`
`glucose level presents a danger, central monitor 105 may activate an
`
`implanted insulin pump to release insulin into the patient’s bloodstream. Id.
`
`Kehr also discloses that the “timing of the transmission depends on
`
`the disease being treated and the treatment regimen being administered” (id.
`
`at 36) and further describes, as an example, “if the disease being treated is a
`
`congestive heart failure condition, and a single response data point indicates
`
`that the patient is suffering moderate or severe chest pain, then the device
`
`
`
`14
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`will immediately transmit the response data to the healthcare provider” (id.
`
`at 35).
`
`
`
`3.
`
`Independent Claim 1
`
`a)
`
`Apparatus with RMU, CU, and Communication Device
`
`In addressing the monitoring apparatus, Petitioner relies on Ferguson
`
`and submits an annotated copy of Ferguson’s Figure 1, which we reproduce
`
`below (Pet. 18–20):
`
`
`
`As annotated by Petitioner in Figure 1, Ferguson’s sensor band 10,
`
`auxiliary sensors, and base station 30 collectively correspond to the claimed
`
`“remote monitoring unit,” or RMU. Id. at 18 (citing Ex. 1002 ¶¶ 120–122).
`
`Petitioner also relies on Ferguson’s remote monitoring station 50 as
`
`corresponding to the claimed “central unit” (or CU), and relies on
`
`Ferguson’s modems as corresponding to the claimed “communications
`
`device.” Id. at 20–21.
`
`
`
`15
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`In addressing the claimed “sensor that measures a physiological
`
`characteristic of the patient,” Petitioner relies on Ferguson’s disclosure that
`
`sensor band 10 is preferably worn on a patient’s chest for measuring vital
`
`signs, and transmits the measured vital signs to base station unit 30. Id. at
`
`18–20 (citing Ex. 1004, 8:29–40).
`
`
`
`b) Monitored Data Set
`
`In addressing the claimed “[RMU] obtaining a monitored data set,”
`
`Petitioner relies on Ferguson’s disclosure that its sensor—sensor band 10—
`
`measures, for example, ECG and respiration data, and it is this data that
`
`corresponds to the claimed “monitored data set.” See Pet. 22 (citing in part
`
`Ex. 1004, 8:44–49).
`
`
`
`c)
`
`Derived Data Set
`
`In addressing the claimed RMU “analyzing the monitored data set to
`
`obtain a derived data set,” Petitioner cites to Ferguson’s disclosure that
`
`RMU calculates heart rate and respiration rate from the ECG and respiration
`
`signals, and it is this calculated heart rate and respiration rate that correspond
`
`to the claimed “derived data set.” Id. at 22 (citing Ex. 1004, 12:19–28,
`
`15:41–45).
`
`In addressing the limitation that the “[RMU determines] from the
`
`derived data set that communication with the [CU] is required,” Petitioner
`
`relies on the testimony of Dr. Stone and asserts that when Ferguson’s RMU
`
`flags an event for download, it determines that communication is required.
`
`Id. at 23 (citing Ex. 1002 ¶ 143). Petitioner cites to Ferguson’s disclosure
`
`that upon detection of a threshold event (or threshold violation, such as a
`
`
`
`16
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`low heart rate), its RMU determines that the event and its related data “need
`
`to be communicated to the CU.” Id. at 23–24 (citations omitted). Ferguson
`
`discloses that flagging events “will be stored on the base station unit 30, and
`
`new events will be downloaded whenever the remote monitoring unit 50 and
`
`base station unit 30 connect.” Ex. 1004, 22:19–21 (emphasis omitted).
`
`In addition to asserting that Ferguson discloses this limitation (see
`
`Pet. 23–24; Ex. 1002 ¶ 147), Petitioner asserts in the alternative that “even if
`
`Ferguson did not teach or suggest that its base station (RMU) determines
`
`from the derived data set (e.g., heart rate) that communication with the CU is
`
`required, that well-known capability would have been an obvious
`
`modification” (id. at 24). Petitioner reasons that a POSITA “would have
`
`been motivated to modify Ferguson’s base station so that it ‘initiate[s] a dial-
`
`up’ when an event is detected (rather than waiting for the next scheduled
`
`transmission) in order to promptly notify medical personnel that the patient
`
`has suffered an event that may warrant immediate care.” Id. at 25 (citing
`
`Ex. 1002 ¶ 147).
`
`
`
`d)
`
`Establishing a Communications Link
`
`In addressing the claimed “establishing a communications link with
`
`the [CU],” Petitioner asserts that Ferguson teaches this step and cites to
`
`Ferguson’s disclosure that “the base station unit 30 could initiate the dial-up
`
`for uploading the stored data.” Pet. 25 (citing Ex. 1004, 13:16–18).
`
`Petitioner also submits an annotated copy of Ferguson’s Figure 5A, which
`
`we reproduce below:
`
`
`
`17
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`
`
`Figure 5A is a block diagram of Ferguson’s system, with annotations
`
`by Petitioner in support of the contention that Ferguson’s “communications
`
`device” “selectively establishes a communication,” as its “RMU” initiates a
`
`dial up connection with “CU” in order to establish a network connection. Id.
`
`at 21 (citing Ex. 1004, 13:16–18, 16:7–13); Ex. 1004, 7:34–36. Ferguson
`
`explicitly discloses that “data is uploaded over communications link 40
`
`using modem 74 of the base station unit 30 and modem 76 of the remote
`
`monitoring station 50.” Ex. 1004, 15:45–50.
`
`
`
`e)
`
`Initially Transmitted Data Set
`
`In addressing the claimed “[RMU] transmitting to the [CU] an
`
`initially transmitted data set related to the monitored data set,” Petitioner
`
`asserts that Ferguson teaches this step, as its RMU “creates a summary of
`
`the collected data for transmission” and transmits this summary to the CU.
`
`Pet. 26 (citing Ex. 1004, 12:28–31). In support of this assertion, Dr. Stone
`
`testifies that “[t]he summary of collected data and event flags are related to
`
`the monitored data set (i.e., collected data) and therefore correspond to the
`
`claimed initially transmitted data set.” Ex. 1002 ¶ 155.
`
`
`
`18
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`
`
`f)
`
`Additional Data Set
`
`In addressing the claimed “[CU] analyzing the initially transmitted
`
`data set to determine whether an additional data set” is required, Petitioner
`
`asserts that Ferguson teaches this step, and cites to Ferguson’s disclosure of
`
`CU’s interface to allow human review. Pet. 26–27 (citing Ex. 1001, 4:38–
`
`41, 5:39–54). Petitioner points out that the operator may then determine if
`
`more detailed information is necessary (id. at 27 (citing Ex. 1001, 14:38–
`
`40)) and, if so, Ferguson’s “remote monitoring station 50 could initiate a
`
`data upload of the designated data from the base station unit 30.” Id. at 27
`
`(citing Ex. 1004, 14:38–42). Petitioner cites to the testimony of Dr. Stone
`
`and asserts that Ferguson’s more detailed information corresponds to the
`
`claimed “additional data set.” Id. (citing Ex. 1002 ¶ 162).
`
`
`
`g)
`
`Time at Which the Additional Data Set is to be Transmitted
`
`In addressing the claimed “[CU], when the additional data set related
`
`to the monitored data set is required, instructing the [RMU] . . . as to a time
`
`at which the additional data set is to be transmitted,” Petitioner relies on a
`
`combination of Ferguson and Kehr. See Pet. 28 (emphasis added). In
`
`particular, Petitioner asserts that “[a]lthough Ferguson teaches scheduling
`
`such data transfers, it does not expressly teach requesting the additional
`
`information to be sent at a time other than immediately[, b]ut Kehr does.”
`
`Id. at 29. In support of its assertion that Kehr teaches this limitation,
`
`Petitioner cites to the following disclosure within Kehr:
`
`In the case where the treatment information comprises
`patient query data, once the patient query data is transmitted to
`the medical monitoring device, the device either promptly
`
`
`
`19
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`executes the Patient Query mode, or stores the patient query data
`for subsequent execution of the Patient Query mode, depending
`on the status of an execution command.
`
`Ex. 1005, 34 (emphases added).
`
`Petitioner asserts that Kehr’s “execution command is based on
`
`medical urgency and determines the transmission timing of the additional
`
`data.” Pet. 29 (citing Ex. 1005, 34–35 (“execution command . . . depends
`
`upon the urgency of receiving responses to the particular queries transmitted
`
`to the device”)). Kehr further discloses that “[t]he timing associated with the
`
`execution command is based on the disease being treated and the treatment
`
`regimen being administered.” Ex. 1005, 35.
`
`Based on the teachings of Kehr and the testimony of Dr. Stone,
`
`Petitioner reasons that a person of ordinary skill in the art “would have been
`
`motivated to modify Ferguson with Kehr’s transmission timing scheme to
`
`efficiently allocate bandwidth and other resources while still ensuring patient
`
`safety.” Pet. 30 (citing Ex. 1002 ¶¶ 109–114, 169–172). In particular,
`
`Petitioner reasons that the proposed combination would: (1) avoid
`
`needlessly tying-up communication lines; (2) conserve battery power, if the
`
`remote unit is battery-powered; and (3) would result in a more-efficient,
`
`less-expensive system that does not needlessly utilize more-expensive
`
`(immediate) bandwidth transmission. See id. at 15–18 (citations omitted).
`
`Petitioner argues that “Kehr’s teaching reflects common sense: urgent or
`
`high priority information takes precedence over less important information.”
`
`Id. at 30.
`
`
`
`
`
`
`
`20
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`4.
`
`Dependent Claims 2 and 11
`
`Claims 2 and 11 depend from claims 1 and 9, respectively, and further
`
`recite, “wherein the monitored data set comprises a cardiogram of the
`
`patient.” Ex. 1001, 7:37–38, 8:34–35.
`
`To address this limitation, Petitioner asserts that Ferguson’s
`
`monitored data set includes a patient’s cardiogram and refers to the same
`
`analysis presented under claim 1. See Pet. 30–31 (citing Ex. 1002 ¶¶ 174–
`
`76; Ex. 1004, 1:14–22, 14:42–49); see also id. at 36.
`
`
`
`5.
`
`Dependent Claim 3
`
`Claim 3 depends from claim 1 and further recites, “wherein the step of
`
`the remote monitoring unit analyzing the monitored data set includes the
`
`step of comparing at least one element of the derived data set to a warning
`
`limit.” Ex. 1001, 7:39–43.
`
`To address this limitation, Petitioner asserts that Ferguson discloses
`
`this step with each threshold corresponding to the claimed “warning limit.”
`
`Pet. 31 (citing Ex. 1002 ¶¶ 178–80).
`
`
`
`6.
`
`Dependent Claims 4 and 12
`
`Claims 4 and 12 depend from claims 1 and 9, respectively, and further
`
`recite, “wherein the step of the central unit instructing the remote monitoring
`
`unit as to a time includes the step of the central unit instructing the remote
`
`monitoring unit to transmit the additional data set substantially
`
`immediately.” Ex. 1001, 7:44–49, 8:36–41.
`
`To address this limitation, Petitioner asserts that Ferguson and Kehr
`
`each teach instructing its remote monitoring unit to transmit the additional
`
`
`
`21
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`data set “substantially immediately.” Pet. 31–32 (citing Ex. 1002 ¶¶ 182–
`
`86); see also id. at 36.
`
`
`
`7.
`
`Dependent Claims 5 and 13
`
`Claims 5 and 13 depend from claims 1 and 9, respectively, and further
`
`recite, “wherein the step of the central unit instructing the remote monitoring
`
`unit as to a time includes the step of the central unit instructing the remote
`
`monitoring unit to transmit the additional data set at a delayed time.” Ex.
`
`1001, 7:50–55, 8:42–47.
`
`To address this limitation, Petitioner asserts that the proposed
`
`combination satisfy the claimed step as the data is transmitted immediately
`
`or at some other time based on urgency. See Pet. 32 (citing Ex. 1002 ¶ 188);
`
`see also id. at 36.
`
`
`
`8.
`
`Dependent Claims 6 and 14
`
`Claims 6 and 14 depend from claims 1 and 9, respectively, and further
`
`recite, “wherein the additional data set and the monitored data set are not the
`
`same.” Ex. 1001, 7:56–57; 8:48–49.
`
`To address this limitation, Petitioner asserts that Ferguson’s
`
`“additional data set” is at most a subset of the larger “monitored data set,”
`
`and are thus “not the same.” See Pet. 32–33 (citing Ex. 1002 ¶¶ 190–91,
`
`193; Ex. 1004, 14:21–25, 24:9–10).
`
`
`
`9.
`
`Independent Claim 9
`
`As with claim 1, independent claim 9 recites a “method of monitoring
`
`a patient” with a “monitoring apparatus” including a “remote monitoring
`
`
`
`22
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`unit,” “central unit,” and “communications device.” Ex. 1001, 8:1–30.
`
`Unlike claim 1, however, claim 9 is broader as it does not recite its “remote
`
`monitoring unit” to include a “sensor,” “obtain a derived data set,” or
`
`“determin[e] from the derived data set that communication with the central
`
`unit is required.” Compare id. at 7:1–36, with id. at 8:1–30.
`
`To address the claim 9, Petitioner relies on the same findings and
`
`reasoning presented in its claim 1 challenge. See Pet. 34–36.
`
`
`
`10.
`
`Independent Claim 16
`
`Claim 16 is nearly identical to claim 1, with the exception being the
`
`last method step, which removes the language “when the additional data set
`
`related to the monitored data set is required” and “received from the remote
`
`monitoring unit,” but adds the language “the step of the central unit
`
`analyzing.” Compare Ex. 1001, 7:1–36, with id. at 8:57–9:21. In particular,
`
`claim 16 recites,
`
`the central unit instructing the remote monitoring unit that the
`additional data set related to the monitored data set is to be
`transmitted from the remote monitoring unit to the central unit
`and as to a time at which the additional data set is to be
`transmitted based on the step of the central unit analyzing the
`initially transmitted data set.
`
`Id. at 8:57–9:21 (emphasis to limitation added).
`
`To address this claim, Petitioner asserts that, as discussed with respect
`
`to claim 1, the combination satisfies the claim and Ferguson’s “central unit”
`
`analyzes the initially transmitted data to determine whether and when
`
`additional data is required. See Pet. 36–37 (citing Ex. 1002 ¶ 212).
`
`
`
`
`
`
`
`23
`
`
`
`IPR2017-00796
`Patent RE43,767
`
`
`11.
`
`Independent Claim 17
`
`Claim 17 is similar to claim 1 with the exception of two claim